MAIA Biotechnology Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company ...

Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026

With our Phase IIa program underway and defined milestones in front of us, we look forward to engaging with investors and potential partners at BIO.” — Christer Rosén, Chairman and Chief Executive ...
STAT

UniQure plans to seek approval for Huntington’s therapy still blocked by FDA

UniQure said Monday that plans to seek approval for its Huntington’s disease treatment with the Food and Drug Administration ...

Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19

BOSTON, MA / ACCESS Newswire / March 2, 2026 / Bioxytran, Inc. (OTCQB:BIXT), a clinical-stage biotechnology company ...

Investment Advisor Bets Big on CMPX Stock, Adds 2.5 Million Shares, According to Latest SEC Filing

This clinical-stage biotech develops antibody therapeutics targeting cancer, with a pipeline focused on oncology and ...

HKUST may reserve 20% of new medical school inaugural intake for non-locals

School to welcome first batch of 50 students in 2028-29, with most non-locals expected to be from mainland China About 20 per ...
The Manila Times

Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform

Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, ...

Rallybio in Reverse Merger With Candid Therapeutics

Rallybio has inked a deal to combine with fellow clinical-stage biotechnology company Candid Therapeutics in an all-stock reverse merger. Rallybio on Monday said its shareholders will own about 3.65% ...
The Punch

Rising costs, climate threaten protein supply – Experts

Experts warn of a protein deficit in Nigeria due to rising costs and climate change, threatening the nation's protein supply ...
The Manila Times

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform ...
Rutland Herald

3T Biosciences Appoints Rebeca Villarreal-Barragan, MBA, as Head of Clinical Operations

T Biosciences, an immunotherapy company changing the future of treatment for solid tumors and other immune-mediated diseases, ...